|
Index of reports
> Cases resulting in disability (7)
> Cases with Visual Field Defect (3)
Below is the selection of adverse event reports related to Diovan HCT (Valsartan / Hydrochlorothiazide) that includes cases resulting in disability where reactions include visual field defect.
Adverse event in 59 year old female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a individual with unspecified qualification from United States on 2007-07-24
Patient: 59 year old female
Adverse reactions / side effects: Hyperlipidaemia, Visual Field Defect, Blood Pressure Inadequately Controlled, Retinal Vein Occlusion, Hypertension, Eye Disorder, Cough
Adverse event resulted in: disablity
Suspect drug(s):
Diovan HCT (Valsartan / Hydrochlorothiazide)
Other drugs received by patient: Tarka - Slow Release; Levoxyl; Percocet
Adverse event in 59 year old female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a individual with unspecified qualification from United States on 2007-07-24
Patient: 59 year old female
Adverse reactions / side effects: Hyperlipidaemia, Visual Field Defect, Blood Pressure Inadequately Controlled, Retinal Vein Occlusion, Eye Disorder, Cough
Adverse event resulted in: disablity
Suspect drug(s):
Diovan HCT (Valsartan / Hydrochlorothiazide)
Other drugs received by patient: Tarka - Slow Release; Levoxyl; Percocet
Adverse event in 59 year old female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a individual with unspecified qualification from United States on 2007-06-05
Patient: 59 year old female
Adverse reactions / side effects: Hyperlipidaemia, Visual Field Defect, Blood Pressure Inadequately Controlled, Retinal Vein Occlusion, Cough
Adverse event resulted in: disablity
Suspect drug(s):
Diovan HCT (Valsartan / Hydrochlorothiazide)
Other drugs received by patient: Tarka - Slow Release; Levoxyl; Percocet
|
